The Interleukin-11/IL-11 Receptor Promotes Glioblastoma Survival and Invasion under Glucose-Starved Conditions through Enhanced Glutaminolysis

Glioblastoma cells adapt to changes in glucose availability through metabolic plasticity allowing for cell survival and continued progression in low-glucose concentrations. However, the regulatory cytokine networks that govern the ability to survive in glucose-starved conditions are not fully defined. In the present study, we define a critical role for the IL-11/IL-11Rα signalling axis in glioblastoma survival, proliferation and invasion when cells are starved of glucose. We identified enhanced IL-11/IL-11Rα expression correlated with reduced overall survival in glioblastoma patients. Glioblastoma cell lines over-expressing IL-11Rα displayed greater survival, proliferation, migration and invasion in glucose-free conditions compared to their low-IL-11Rα-expressing counterparts, while knockdown of IL-11Rα reversed these pro-tumorigenic characteristics. In addition, these IL-11Rα-over-expressing cells displayed enhanced glutamine oxidation and glutamate production compared to their low-IL-11Rα-expressing counterparts, while knockdown of IL-11Rα or the pharmacological inhibition of several members of the glutaminolysis pathway resulted in reduced survival (enhanced apoptosis) and reduced migration and invasion. Furthermore, IL-11Rα expression in glioblastoma patient samples correlated with enhanced gene expression of the glutaminolysis pathway genes GLUD1, GSS and c-Myc. Overall, our study identified that the IL-11/IL-11Rα pathway promotes glioblastoma cell survival and enhances cell migration and invasion in environments of glucose starvation via glutaminolysis.

[1]  H. Steiger,et al.  Overexpression of Cystine/Glutamate Antiporter xCT Correlates with Nutrient Flexibility and ZEB1 Expression in Highly Clonogenic Glioblastoma Stem-like Cells (GSCs) , 2021, Cancers.

[2]  Y. Guan,et al.  The diagnostic value of lower glucose consumption for IDH1 mutated gliomas on FDG-PET , 2021, BMC cancer.

[3]  Ya Chun Yu,et al.  Glutamine reliance in cell metabolism , 2020, Experimental & Molecular Medicine.

[4]  E. Arbustini,et al.  A New Pathway Promotes Adaptation of Human Glioblastoma Cells to Glucose Starvation , 2020, Cells.

[5]  M. Parker,et al.  The structure of the extracellular domains of human interleukin 11α receptor reveals mechanisms of cytokine engagement , 2020, The Journal of Biological Chemistry.

[6]  Wancai Yang,et al.  EGFR activates GDH1 transcription to promote glutamine metabolism through MEK/ERK/ELK1 pathway in glioblastoma , 2020, Oncogene.

[7]  Y. Wan,et al.  Metabolic Reprogramming in Mitochondria of Myeloid Cells , 2019, Cells.

[8]  S. Venneti,et al.  Glutamine Metabolism in Brain Tumors , 2019, Cancers.

[9]  P. Mischel,et al.  Acyl-CoA-Binding Protein Fuels Gliomagenesis. , 2019, Cell metabolism.

[10]  A. Korshunov,et al.  Acyl-CoA-Binding Protein Drives Glioblastoma Tumorigenesis by Sustaining Fatty Acid Oxidation. , 2019, Cell metabolism.

[11]  A. Shakoori,et al.  Low glucose availability alters the expression of genes involved in initial adhesion of human glioblastoma cancer cell line SF767 , 2019, Journal of cellular biochemistry.

[12]  Yun Bai,et al.  IL-11 is essential in promoting osteolysis in breast cancer bone metastasis via RANKL-independent activation of osteoclastogenesis , 2019, Cell Death & Disease.

[13]  Chin Wee Tan,et al.  Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth , 2019, EMBO molecular medicine.

[14]  Zhouxun Chen,et al.  SIRT4 inhibits the proliferation, migration, and invasion abilities of thyroid cancer cells by inhibiting glutamine metabolism , 2019, OncoTargets and therapy.

[15]  Jiayuh Lin,et al.  Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy , 2019, Journal of experimental & clinical cancer research : CR.

[16]  O. Sieber,et al.  Ponatinib Inhibits Multiple Signaling Pathways Involved in STAT3 Signaling and Attenuates Colorectal Tumor Growth , 2018, Cancers.

[17]  A. Rasola,et al.  Metabolic Plasticity of Tumor Cell Mitochondria , 2018, Front. Oncol..

[18]  S. Stylli,et al.  The role of interleukin-6-STAT3 signalling in glioblastoma , 2018, Oncology letters.

[19]  X. Che,et al.  Cancer‐associated fibroblasts‐stimulated interleukin‐11 promotes metastasis of gastric cancer cells mediated by upregulation of MUC1 , 2018, Experimental cell research.

[20]  Shuo Wang,et al.  MicroRNA-124a inhibits cell proliferation and migration in liver cancer by regulating interleukin-11. , 2017, Molecular medicine reports.

[21]  C. Garbers,et al.  Proteolytic control of Interleukin-11 and Interleukin-6 biology. , 2017, Biochimica et biophysica acta. Molecular cell research.

[22]  R. Teusan,et al.  Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity , 2017, Clinical Cancer Research.

[23]  S. Venneti,et al.  Glutaminolysis: A Hallmark of Cancer Metabolism. , 2017, Annual review of biomedical engineering.

[24]  A. Plaitakis,et al.  The Glutamate Dehydrogenase Pathway and Its Roles in Cell and Tissue Biology in Health and Disease , 2017, Biology.

[25]  Jiayuh Lin,et al.  Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy , 2016, Molecular Cancer Therapeutics.

[26]  Maristela L Onozato,et al.  Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma , 2016, Clinical Cancer Research.

[27]  W. Ritchie,et al.  ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer , 2015, Oncogene.

[28]  Eytan Ruppin,et al.  Glutamine Synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma , 2015, Nature Cell Biology.

[29]  T. Putoczki,et al.  Emerging roles for IL-11 signaling in cancer development and progression: Focus on breast cancer. , 2015, Cytokine & growth factor reviews.

[30]  Heng-hua Cui,et al.  Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach , 2015, International journal of molecular sciences.

[31]  P. Mischel,et al.  Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment. , 2015, The Journal of clinical investigation.

[32]  R. Deberardinis,et al.  Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport. , 2014, Molecular cell.

[33]  E. Cheng,et al.  Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion. , 2014, Molecular cell.

[34]  Prahlad T. Ram,et al.  Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer , 2014, Molecular systems biology.

[35]  Jukka Westermarck,et al.  ColonyArea: An ImageJ Plugin to Automatically Quantify Colony Formation in Clonogenic Assays , 2014, PloS one.

[36]  M. Rottenberg,et al.  SOCS3, a Major Regulator of Infection and Inflammation , 2014, Front. Immunol..

[37]  M. Karin,et al.  IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. , 2014, Seminars in immunology.

[38]  Andrew E. Sloan,et al.  Brain Tumor Initiating Cells Adapt to Restricted Nutrition through Preferential Glucose Uptake , 2013, Nature Neuroscience.

[39]  O. Sieber,et al.  Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically. , 2013, Cancer cell.

[40]  C. Dang.  MYC, metabolism, cell growth, and tumorigenesis. , 2013, Cold Spring Harbor perspectives in medicine.

[41]  J. Matés,et al.  Glutaminase isoenzymes as key regulators in metabolic and oxidative stress against cancer. , 2013, Current molecular medicine.

[42]  R. Deberardinis,et al.  Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo. , 2012, Cell metabolism.

[43]  S. Rose-John,et al.  A designer hyper interleukin 11 (H11) is a biologically active cytokine , 2012, BMC Biotechnology.

[44]  Takashi Tsukamoto,et al.  Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. , 2012, Cell metabolism.

[45]  Pierre J Magistretti,et al.  Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. , 2011, Cell metabolism.

[46]  B. Faubert,et al.  Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress. , 2011, Genes & development.

[47]  G. Barnett,et al.  Phase II trial of ritonavir/lopinavir in patients with progressive or recurrent high-grade gliomas , 2011, Journal of Neuro-Oncology.

[48]  C. Dang,et al.  Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. , 2010, Cancer cell.

[49]  C. Thompson,et al.  Glutamine addiction: a new therapeutic target in cancer. , 2010, Trends in biochemical sciences.

[50]  R. Deberardinis,et al.  Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling. , 2009, Cancer research.

[51]  P. Kleihues,et al.  IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas , 2009, Clinical Cancer Research.

[52]  Jennifer E. Van Eyk,et al.  c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism , 2016 .

[53]  Anthony Mancuso,et al.  Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction , 2008, Proceedings of the National Academy of Sciences.

[54]  Gregory Stephanopoulos,et al.  Quantifying Reductive Carboxylation Flux of Glutamine to Lipid in a Brown Adipocyte Cell Line* , 2008, Journal of Biological Chemistry.

[55]  J. Karras,et al.  STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. , 2008, Journal of Clinical Investigation.

[56]  R. Deberardinis,et al.  Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis , 2007, Proceedings of the National Academy of Sciences.

[57]  L. Chin,et al.  Malignant astrocytic glioma: genetics, biology, and paths to treatment. , 2007, Genes & development.

[58]  T. Seyfried,et al.  Targeting energy metabolism in brain cancer: review and hypothesis , 2005, Nutrition & metabolism.

[59]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.